Gemina Laboratories Statistics

Total Valuation

Gemina Laboratories has a market cap or net worth of CAD 47.73 million. The enterprise value is 48.71 million.

Market Cap	47.73M
Enterprise Value	48.71M

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Gemina Laboratories has 74.57 million shares outstanding. The number of shares has increased by 8.52% in one year.

Current Share Class	n/a
Shares Outstanding	74.57M
Shares Change (YoY)	+8.52%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	1.00%
Owned by Institutions (%)	n/a
Float	36.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.09

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.88
Interest Coverage	-36.61

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-134.85%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-620,605
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.86% in the last 52 weeks. The beta is 0.10, so Gemina Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+17.86%
50-Day Moving Average	0.43
200-Day Moving Average	0.46
Relative Strength Index (RSI)	67.91
Average Volume (20 Days)	19,999

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.61M
Pretax Income	-3.72M
Net Income	-3.72M
EBITDA	-3.59M
EBIT	-3.61M
Earnings Per Share (EPS)	-0.05

Full Income Statement

Balance Sheet

The company has 206,845 in cash and 1.19 million in debt, giving a net cash position of -980,801 or -0.01 per share.

Cash & Cash Equivalents	206,845
Total Debt	1.19M
Net Cash	-980,801
Net Cash Per Share	-0.01
Equity (Book Value)	-2.66M
Book Value Per Share	-0.04
Working Capital	-3.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.35 million and capital expenditures 4,199, giving a free cash flow of -1.35 million.

Operating Cash Flow	-1.35M
Capital Expenditures	4,199
Free Cash Flow	-1.35M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gemina Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.52%
Shareholder Yield	-8.52%
Earnings Yield	-7.93%
FCF Yield	-2.83%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a